EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $761 | -40.1% | 39,166 | -12.5% | 0.01% | -53.3% |
| Q1 2023 | $1,270 | -28.8% | 44,783 | -26.7% | 0.02% | -40.0% |
| Q4 2022 | $1,784 | -99.7% | 61,059 | +296.8% | 0.02% | +257.1% |
| Q2 2022 | $683,000 | -8.7% | 15,389 | +1.7% | 0.01% | +40.0% |
| Q1 2022 | $748,000 | -24.7% | 15,126 | -22.5% | 0.01% | -16.7% |
| Q4 2021 | $993,000 | +102.7% | 19,513 | +122.0% | 0.01% | +100.0% |
| Q3 2021 | $490,000 | – | 8,791 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |